Accessibility Menu
 
Third Harmonic Bio logo

Third Harmonic Bio

(NASDAQ) THRD

Current PriceN/A
Market CapN/A
Since IPO (2022)-73%
5 YearN/A
1 Year-57%
1 Month-1%

Third Harmonic Bio Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$48.00K

Net Income (TTM)

$53.45M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

THRD News

No articles available.

THRD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Third Harmonic Bio

Industry

Pharmaceuticals

Employees

31

CEO

Natalie C. Holles

Headquarters

Cambridge, MA 02139, US

THRD Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-1088%

Net Income Margin

-890%

Return on Equity

-15%

Return on Capital

-19%

Return on Assets

-15%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$49.00K

Operating Income

$58.87M

EBITDA

$45.42M

Operating Cash Flow

$34.50M

Capital Expenditure

$10.00K

Free Cash Flow

$34.51M

Cash & ST Invst.

$285.06M

Total Debt

$3.21M

Third Harmonic Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$13.00K

-8.3%

Gross Margin

N/A

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

31

N/A

Net Income

$15.83M

-101.6%

EBITDA

$18.70M

-65.8%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Net Cash

$268.61M

+3.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.11M

-29.6%

Short Term Debt

$889.00K

-42.5%

Return on Assets

-15.27%

N/A

Return on Invested Capital

-19.01%

N/A

Free Cash Flow

$13.48M

-114.2%

Operating Cash Flow

$13.48M

-114.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INZYInozyme Pharma, Inc.
$4.00+0.25%
SLRNAcelyrin, Inc.
$2.27+0.00%
SPPISpectrum Pharmaceuticals, Inc.
$1.02-0.49%
CRGXCARGO Therapeutics, Inc. Common Stock
$4.47+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.95-0.32%
TQQQProShares Trust - ProShares UltraPro Qqq
$42.95-0.06%
ANNAAleAnna
$6.95+0.83%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.78+0.06%

Questions About THRD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.